FDA Gives Motiva Implants the Thumbs Up

FDA Gives Motiva Implants the Thumbs Up

“I’m delighted to have the opportunity to participate in a study that has the potential to bring new insights to the breast aesthetic and reconstruction industry. Motiva Implants are innovative and differentiated, and we hope that these innovations will show significantly improved patient outcomes,” said Dr. Caroline Glicksman, a board certified plastic surgeon and Medical Director of the Motiva Implants clinical trial.

Read More

Aesthetic Surgery Journal Publishes Positive Motiva Implant Study

Aesthetic Surgery Journal Publishes Positive Motiva Implant Study

The study evaluated the experience of 5,813 consecutive female patients receiving Motiva Implants for breast augmentation, from 2013 to 2016.

Clinical highlights of the clinical study included:

  • Total reoperation occurred at a rate of 0.76% (95% confidence interval)
  • No serious adverse events or cases of implant rupture or device failure were observed
  • No incidences of capsular contracture in primary cases, late seroma, asymmetry, persistent swelling, breast pain or rippling
  • Low rates of early complications with no late complications reported
  • Motiva SilkSurface® resulted in lower complication rates compared to Motiva VelvetSurface® implants
Read More